| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.23 | 7e-11 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |